Efficacy of Exenatide-LAR Alone and in Combination With Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Uncontrolled Type 2 Diabetes
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Exenatide (Primary) ; Dapagliflozin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Dexlar
- 01 Mar 2017 Status changed from recruiting to withdrawn prior to enrolment due to inability to enroll as there is widespread use of both classes of drugs in patients with T2DM, including those on concomitant insulin therapy.
- 22 Jul 2016 New trial record